Lipotropin 100 mcg, 60 capsules

LIPOTROPIN 100mcg

AOD9604 is a peptide fragment of the C-terminus or lipolytic domain of hGH (hGH 177-191), with an additional tyrosine residue at the N-terminus for stabilization. Studies in vitro and in preclinical models have described similarities between AOD9604 and hGH on selected readouts related to lipid metabolism under experimental conditions. The literature also indicates that AOD9604 is sometimes analyzed for a profile of distinct readouts relative to growth-dependent signaling pathways of hGH.

AOD9604 has been studied in the area of growth hormone-related pathways and repair and remodeling processes in experimental models. It has also been described in the context of analyses involving lipid metabolism and metabolic biomarkers under controlled conditions.

Lipid metabolism remains an important area of research in the context of global trends related to body weight and metabolic functioning. The literature highlights that hGH is involved in the regulation of lipolysis and lipogenesis, which has provided a starting point for the design and study of peptide fragments aimed at a mechanistic understanding of these pathways.

Between 2001 and 2006, clinical trial programs for the hexadecapeptide AOD9604 were described, involving adult populations under specific study criteria. These reports focused on assessment of tolerance parameters and monitoring of selected laboratory markers (including IGF-1 and readings related to glucose-insulin metabolism) within an established methodology. Interpretation of such data remains dependent on study design, endpoint selection and replication in independent work, and is not an indication for use in humans.